These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17075781)

  • 41. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The differentiated treatment of non-insulin-dependent diabetes mellitus (a review of the literature and the author's own data)].
    Pan'kiv VI
    Lik Sprava; 1996; (10-12):35-41. PubMed ID: 9138810
    [No Abstract]   [Full Text] [Related]  

  • 43. [Oral drug therapy of diabetes mellitus from the standpoint of blood insulin values].
    Murakami M; Takeda R; Miyabo S; Morimoto S; Fujimura A
    Saishin Igaku; 1967 Oct; 22(10):2311-9. PubMed ID: 5588196
    [No Abstract]   [Full Text] [Related]  

  • 44. A clinician's view of the role of insulin and why it should be better used.
    Manag Care Interface; 2003; Suppl C():15-7. PubMed ID: 14569632
    [No Abstract]   [Full Text] [Related]  

  • 45. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents.
    Ekpebegh CO; Coetzee EJ; van der Merwe L; Levitt NS
    Diabet Med; 2007 Mar; 24(3):253-8. PubMed ID: 17305787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on systemic management of diabetes.
    Masharani U; Rushakoff RJ
    Int Ophthalmol Clin; 2009; 49(2):13-33. PubMed ID: 19349784
    [No Abstract]   [Full Text] [Related]  

  • 47. [Glucose-lactic acid metabolism during clinical use of biguanides].
    Pedersen J
    Ugeskr Laeger; 1973 Jul; 135(31):1632-5. PubMed ID: 4585752
    [No Abstract]   [Full Text] [Related]  

  • 48. [Mode of action of blood glucose lowering biguanides: clinical aspects].
    Mehnert H
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():678-84. PubMed ID: 4906985
    [No Abstract]   [Full Text] [Related]  

  • 49. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Statistical data from the diabetic care and control station of the Medical University Clinic in Innsbruck].
    Leubner H
    Wien Klin Wochenschr; 1966 Oct; 78(43):739-41. PubMed ID: 5996748
    [No Abstract]   [Full Text] [Related]  

  • 51. The natural history of diabetes mellitus.
    Rosenbloom AL
    J Fla Med Assoc; 1971 May; 58(5):31-4. PubMed ID: 5573444
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P
    Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of hypoglycemic brittle diabetes with peripheral edema successfully managed by conversion from insulin lispro to insulin aspart.
    Tone A; Shikata K; Nakagawa K; Hashimoto M; Makino H
    Diabetes Res Clin Pract; 2008 Sep; 81(3):e15-6. PubMed ID: 18676048
    [No Abstract]   [Full Text] [Related]  

  • 56. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
    Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
    Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Current data on the treatment of diabetics with Adebit].
    Pogátsa G
    Orv Hetil; 1970 Apr; 111(15):847-50. PubMed ID: 5439169
    [No Abstract]   [Full Text] [Related]  

  • 58. [Biguanides, glycemia and insulinemia (author's transl)].
    Kulenda Z; Dub O
    Cas Lek Cesk; 1974 Sep; 113(39):1201-3. PubMed ID: 4424987
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical observations on the combination of glycyclamide and dimethylbiguanide in the treatment of diabetes in the aged].
    Trezzini C; Splendori F
    Clin Ter; 1969 Apr; 49(1):23-34. PubMed ID: 5405074
    [No Abstract]   [Full Text] [Related]  

  • 60. [Late failures of oral therapy of diabetes].
    Kaeding A; Werner P
    Dtsch Z Verdau Stoffwechselkr; 1965 Nov; 25(5):305-12. PubMed ID: 5888991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.